Human milk pasteurization: benefits and risks

被引:66
|
作者
O'Connor, Deborah L. [1 ,3 ]
Ewaschuk, Julia B. [4 ]
Unger, Sharon [1 ,2 ,5 ]
机构
[1] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada
[2] Univ Toronto, Dept Paediat & Neonatol, Toronto, ON M5S 3E2, Canada
[3] Hosp Sick Children, Physiol & Expt Med Program, Toronto, ON M5G 1X8, Canada
[4] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada
[5] Mt Sinai Hosp, Dept Paediat, Toronto, ON M5G 1X5, Canada
关键词
donor milk; human milk; pasteurization; preterm infants; DONOR HUMAN-MILK; MOTHERS OWN MILK; NECROTIZING ENTEROCOLITIS; HOLDER PASTEURIZATION; PRETERM INFANTS; COST; CYTOKINES; FEEDINGS; REDUCE; GROWTH;
D O I
10.1097/MCO.0000000000000160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewRecent findings substantiate that the optimal method of nourishing preterm, very low birth weight infants (VLBW, born <1500g) is through appropriately nutrient-enriched human milk, which is frequently provided as pasteurized donor milk. The availability of donor milk for VLBW infants during initial hospitalization continues to increase with the launch of new milk banks in North America. The majority of North American neonatal ICUs now have written policies governing the provision of donor milk. The purpose of this review is to summarize recent evidence regarding the risks and benefits of pasteurization of human milk and outcomes associated with its provision to VLBW preterm infants.Recent findingsStudies investigating the impact of collection, storage and pasteurization on the bacteriostatic, immunologic and nutritional aspects of human milk continue to be published, generally revealing a partial, but not complete reduction in bioactivity. Risk of contamination of pasteurized donor human milk with pathogenic agents is mitigated through pasteurization. New pasteurization methods aiming to maintain the safety of pooled human milk while better preserving bioactivity are under investigation.SummaryProvision of a human milk-derived diet to preterm VLBW infants is associated with improved outcomes.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [1] The Risks and Benefits of Human Donor Breast Milk
    Brent, Nancy
    PEDIATRIC ANNALS, 2013, 42 (05): : 84 - 90
  • [2] Contaminants in human milk: Weighing the risks against the benefits of breastfeeding
    Mead, M. Nathaniel
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2008, 116 (10) : A427 - A434
  • [3] Pasteurization of banked human breast milk
    Menon, Manoj P.
    Sobel, Jeremy
    Tauxe, Robert V.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (03) : 277 - 278
  • [4] Pasteurization of human milk for inactivation of cytomegalovirus
    Schreiner, Christine
    Muller, Andreas
    Dresbach, Till
    MONATSSCHRIFT KINDERHEILKUNDE, 2022, 170 (06) : 558 - 559
  • [5] PASTEURIZATION OF HUMAN MILK - MICROBIOLOGICAL AND IMMUNOLOGICAL EFFECTS
    GIBBS, JH
    BAUM, JD
    PEDIATRIC RESEARCH, 1977, 11 (09) : 1021 - 1021
  • [6] Impact of pasteurization on the antibacterial properties of human milk
    Marjan Van Gysel
    Veerle Cossey
    Steffen Fieuws
    Annette Schuermans
    European Journal of Pediatrics, 2012, 171 : 1231 - 1237
  • [7] Effects of holder pasteurization on human milk oligosaccharides
    Giuliani, F.
    Bertino, E.
    Coppa, G. V.
    Gabrielli, O.
    Zampini, L.
    Testa, T.
    Peila, C.
    Coscia, A.
    Fabris, C.
    PROCEEDINGS OF THE 8TH WORLD CONGRESS OF PERINATAL MEDICINE, 2007, : 453 - 458
  • [8] Effect of Pasteurization on the Bactericidal Capacity of Human Milk
    Silvestre, D.
    Ruiz, P.
    Martinez-Costa, C.
    Plaza, A.
    Lopez, M. C.
    JOURNAL OF HUMAN LACTATION, 2008, 24 (04) : 371 - 376
  • [9] Impact of pasteurization on the antibacterial properties of human milk
    Van Gysel, Marjan
    Cossey, Veerle
    Fieuws, Steffen
    Schuermans, Annette
    EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (08) : 1231 - 1237
  • [10] The effect of pasteurization on cytokines in human milk.
    Untalan, P. B.
    Keeney, S. E.
    Rivera, A., Jr.
    Goldman, A. S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S288 - S288